Insights

Get insight from our experts and leaders on biopharmaceutical manufacturing trends and innovation.

Gamma Irradiation Sterilization Validation for Single-Use Systems

This study validates gamma irradiation sterilization methods for single-use bioprocessing systems, demonstrating effective sterility assurance using VDmax27.5 method.

Particulate Control in Single-Use System Manufacturing

A comprehensive framework for particulate control and quality assurance in cleanroom manufacturing of bioprocessing systems.

Extended Leak Tightness Study: SaniSure® Clamp Performance in Pre- and Post-Gamma Applications

The study addresses the critical challenge of maintaining leak-tight connections in bioprocessing assemblies over extended storage periods.

SaniSure® Clamp: Design Advantages for Modern Bioprocessing

SaniSure® clamp design overcomes limitations of traditional TC clamps when securing flexible, disposable sanitary fittings in bioprocessing applications.

The Puzzle-Solving CEO

This podcast episode of Molecule to Market explores the dynamic world of global drug development with our SaniSure® CEO, Steven Chevillotte.

Superior Performance of SaniSure® Pharm-A-Clear LH Tubing

This whitepaper explores the critical role of silicone tubing in aseptic parenteral drug production, focusing on the fill/finish process—a vital phase where sterility is paramount.

Setting the Cold Standard

This new study details innovative solution to tackling biological drug substance freezing challenges.

Let’s get started.

See how our industry leading solutions can optimize your mRNA manufacturing flow paths.

contact us

Meet the Experts

Dr. Alex Van Hagen, Molecular Biology
Global Product Line Manager

About:

Dr. Alex Van Hagen is a seasoned professional with over 10 years of experience in research and commercial biotechnology, specializing in product development and commercialization. He currently serves as the Global Product Line Manager for Drug Product Filling at SaniSure, where he leads cross-functional teams in bringing innovative biotech technologies to market. Dr. Van Hagen holds a Ph.D. in Molecular Biology from the University of Nottingham and has a proven track record of driving projects from concept through regulatory approval and market launch.

Fun fact:

Since moving to Alberta, Canada two years ago with a prominent British accent, nearly all Canadians think he is Australian.

Insights

Get insight from our experts and leaders on biopharmaceutical manufacturing trends and innovation.

Let’s get started.

Meet the Experts

Dr. Alex Van Hagen, Molecular BiologyGlobal Product Line Manager

Dr. Alex Van Hagen, Molecular Biology
Global Product Line Manager